Expression profiling of major histocompatibility and natural killer complex genes reveals candidates for controlling risk of graft versus host disease

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Novota, Peter ^a,f   Zinöcker, Severin ^b   Norden, Jean ^c   Wang, Xiao Nong ^c   Sviland, Lisbet ^d   Opitz, Lennart ^a   Salinas Riester, Gabriela ^a   Rolstad, Bent ^b   Dickinson, Anne M ^c   Walter, Lutz ^e   Dressel, Ralf ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF OSLO   (Norway)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF BERGEN   (Norway)

^e GERMAN PRIMATE CENTER   (Germany)

^f INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NATURAL KILLER CELL RECEPTOR; BIOLOGICAL MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; DNA MICROARRAY; EXPLANT; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC RISK; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SKIN DEFECT; ANIMAL; GENETICS; RAT STRAIN; RISK; SKIN DISEASE;

RATTUS;

ANIMALS; BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; GRAFT VS HOST DISEASE; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; RATS; RATS, INBRED STRAINS; RECEPTORS, NATURAL KILLER CELL; RISK; SKIN DISEASES;

EID: 79551537859     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016582     Document Type: Article

References (79)

1. Dickinson AM, Middleton PG, Rocha V, Gluckman E, Holler E (2004) Genetic polymorphisms predicting the outcome of bone marrow transplants. Br J Haematol 127: 479-490.
2. Flomenberg N, Baxter-Lowe LA, Confer D, Fernandez-Vina M, Filipovich A, et al. (2004) Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 104: 1923-1930.
3. Dickinson AM (2008) Non-HLA genetics and predicting outcome in HSCT. Int J Immunogenet 35: 375-380.
4. Hahn T, McCarthy PL, Jr., Zhang MJ, Wang D, Arora M, et al. (2008) Risk factors for acute graft-versus-host disease after human leukocyte antigenidentical sibling transplants for adults with leukemia. J Clin Oncol 26: 5728-5734.
5. Arora M, Weisdorf DJ, Spellman SR, Haagenson MD, Klein JP, et al. (2009) HLA-identical sibling compared with 8/8 matched and mismatched unrelated donor bone marrow transplant for chronic phase chronic myeloid leukemia. J Clin Oncol 27: 1644-1652.
6. Yakoub-Agha I, Mesnil F, Kuentz M, Boiron JM, Ifrah N, et al. (2006) Allogeneic marrow stem-cell transplantation from human leukocyte antigenidentical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol 24: 5695-5702.
7. Consortium TMS (1999) Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature 401: 921-923.
8. Malkki M, Gooley TA, Horowitz MM, Absi L, Christiansen FT, et al. (2007) Mapping MHC-resident transplantation determinants. Biol Blood Marrow Transplant 13: 986-995.
9. Consortium TIH, (2005) A haplotype map of the human genome. Nature 437: 1299-1320.
10. Horton R, Gibson R, Coggill P, Miretti M, Allcock RJ, et al. (2008) Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics 60: 1-18.
11. Miretti MM, Walsh EC, Ke X, Delgado M, Griffiths M, et al. (2005) A highresolution linkage-disequilibrium map of the human major histocompatibility complex and first generation of tag single-nucleotide polymorphisms. Am J Hum Genet 76: 634-646.
12. Petersdorf EW, Malkki M, Gooley TA, Martin PJ, Guo Z (2007) MHC haplotype matching for unrelated hematopoietic cell transplantation. PLoS Med 4: e8.
13. Dickinson AM, Harrold JL, Cullup H (2007) Haematopoietic stem cell transplantation: can our genes predict clinical outcome? Expert Rev Mol Med 9: 1-19.
14. Dressel R, Walter L, Günther E (2001) Genomic and funtional aspects of the rat MHC, the RT1 complex. Immunol Rev 184: 82-95.
15. Günther E, Walter L (2001) The major histocompatibility complex of the rat (Rattus norvegicus). Immunogenetics 53: 520-542.
16. Hurt P, Walter L, Sudbrak R, Klages S, Mü ller I, et al. (2004) The genomic sequence and comparative analysis of the rat major histocompatibility complex. Genome Res 14: 631-639.
17. Naper C, Ryan JC, Kirsch R, Butcher GW, Rolstad B, et al. (1999) Genes in two major histocompatibility complex class I regions control selection, phenotype, and function of a rat Ly-49 natural killer cell subset. Eur J Immunol 29: 2046-2053.
18. Naper C, Dai KZ, Kveberg L, Rolstad B, Niemi EC, et al. (2005) Two structurally related rat Ly49 receptors with opposing functions (Ly49 stimulatory receptor 5 and Ly49 inhibitory receptor 5) recognize nonclassical MHC class Ibencoded target ligands. J Immunol 174: 2702-2711.
19. Kelley J, Walter L, Trowsdale J (2005) Comparative genomics of natural killer cell receptor gene clusters. PLoS Genet 1: 129-139.
20. Sviland L, Hromadnikova I, Sedlacek P, Cermakova M, Stechova K, et al. (2001) Histological correlation between different centers using the skin explant model to predict graft-versus-host disease following bone marrow transplantation. Hum Immunol 62: 1277-1281.
21. Dickinson AM, Wang XN, Sviland L, Vyth-Dreese FA, Jackson GH, et al. (2002) In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens. Nat Med 8: 410-414.
22. Novota P, Sviland L, Zinöcker S, Stocki P, Balavarca Y, et al. (2008) Correlation of Hsp70-1 and Hsp70-2 gene expression with the degree of graft-versus-host reaction in a rat skin explant model. Transplantation 85: 1809-1816.
23. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, et al. (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13: 2129-2141.
24. Pfaffl MW (2001) A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res 29: e45.
25. Leong LY, Le Rolle AF, Deverson EV, Powis SJ, Larkins AP, et al. (1999) RT1-U: identification of a novel, active, class Ib alloantigen of the rat MHC. J Immunol 162: 743-752.
26. Klempnauer J, Wonigeit K, Steiniger B, Günther E, Pichlmayr R (1983) Pancreas whole organ transplantation in the rat: differential effect of individual MHC regions. Transplant Proc 15: 1308-1310.
27. Klempnauer J, Steiniger B, Luck R, Günther E (1989) Genetic control of rat heart allograft rejection: effect of different MHC and non-MHC incompatibilities. Immunogenetics 30: 81-88.
28. Salgar SK, Kunz HW, Gill TJ, 3rd (1995) Nucleotide sequence and structural analysis of the rat RT1.Eu and RT1.Aw3l genes, and of genes related to RT1.O and RT1.C. Immunogenetics 42: 244-253.
29. Lau P, Lorenzi R, Joly E (2000) Comparison of RT-BM1 sequences from six different rat major histocompatibility complex haplotypes reveals limited variation, and alternate splicing in the 39 untranslated region. Immunogenetics 51: 148-153.
30. Kveberg L, Jimenez-Royo P, Naper C, Rolstad B, Butcher GW, et al. (2010) Two complementary rat NK cell subsets, Ly49s3+ and NKR-P1B+, differ inphenotypic characteristics and responsiveness to cytokines. J Leukoc Biol 88: 87-93.
31. Kraft JR, Vance RE, Pohl J, Martin AM, Raulet DH, et al. (2000) Analysis of Qa-1(b) peptide binding specificity and the capacity of CD94/NKG2A to discriminate between Qa-1-peptide complexes. J Exp Med 192: 613-624.
32. Utans U, Arceci RJ, Yamashita Y, Russell ME (1995) Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection. J Clin Invest 95: 2954-2962.
33. Utans U, Quist WC, McManus BM, Wilson JE, Arceci RJ, et al. (1996) Allograft inflammatory factory-1. A cytokine-responsive macrophage molecule expressed in transplanted human hearts. Transplantation 61: 1387-1392.
34. Autieri MV, Kelemen S, Thomas BA, Feller ED, Goldman BI, et al. (2002) Allograft inflammatory factor-1 expression correlates with cardiac rejection and development of cardiac allograft vasculopathy. Circulation 106: 2218-2223.
35. Rollinger-Holzinger I, Eibl B, Pauly M, Griesser U, Hentges F, et al. (2000) LST1: a gene with extensive alternative splicing and immunomodulatory function. J Immunol 164: 3169-3176.
36. Mulcahy H, O'Rourke KP, Adams C, Molloy MG, O'Gara F (2006) LST1 and NCR3 expression in autoimmune inflammation and in response to IFN-gamma, LPS and microbial infection. Immunogenetics 57: 893-903.
37. Wu MX (2003) Roles of the stress-induced gene IEX-1 in regulation of cell death and oncogenesis. Apoptosis 8: 11-18.
38. Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF (1998) IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science 281: 998-1001.
39. Schilling D, Pittelkow MR, Kumar R (2001) IEX-1, an immediate early gene, increases the rate of apoptosis in keratinocytes. Oncogene 20: 7992-7997.
40. Shen L, Guo J, Santos-Berrios C, Wu MX (2006) Distinct domains for anti- and pro-apoptotic activities of IEX-1. J Biol Chem 281: 15304-15311.
41. Ioannidu S, Walter L, Dressel R, Günther E (2001) Physical map and expression profile of genes of the telomeric class I gene region of the rat MHC. J Immunol 166: 3957-3965.
42. Raasi S, Schmidtke G, Groettrup M (2001) The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J Biol Chem 276: 35334-35343.
43. Hipp MS, Kalveram B, Raasi S, Groettrup M, Schmidtke G (2005) FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol Cell Biol 25: 3483-3491.
44. Bates EE, Ravel O, Dieu MC, Ho S, Guret C, et al. (1997) Identification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cells. Eur J Immunol 27: 2471-2477.
45. Holm SJ, Carlen LM, Mallbris L, Stahle-Backdahl M, O'Brien KP (2003) Polymorphisms in the SEEK1 and SPR1 genes on 6p21.3 associate with psoriasis in the Swedish population. Exp Dermatol 12: 435-444.
46. Cao X, Cismowski MJ, Sato M, Blumer JB, Lanier SM (2004) Identification and characterization of AGS4: a protein containing three G-protein regulatory motifs that regulate the activation state of Gialpha. J Biol Chem 279: 27567-27574.
47. Aguado B, Campbell RD (1995) The novel gene G17, located in the human major histocompatibility complex, encodes PBX2, a homeodomain-containing protein. Genomics 25: 650-659.
48. Mallya M, Campbell RD, Aguado B (2002) Transcriptional analysis of a novel cluster of LY-6 family members in the human and mouse major histocompatibility complex: five genes with many splice forms. Genomics 80: 113-123.
49. Mallya M, Campbell RD, Aguado B (2006) Characterization of the five novel Ly-6 superfamily members encoded in the MHC, and detection of cells expressing their potential ligands. Protein Sci 15: 2244-2256.
50. Socie G, Mary JY, Lemann M, Daneshpouy M, Guardiola P, et al. (2004) Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versushost disease of the gastrointestinal tract in humans: TNF and Fas expression. Blood 103: 50-57.
51. Baker KS, Allen RD, Roths JB, Sidman CL (1995) Kinetic and organ-specific patterns of cytokine expression in acute graft-versus-host disease. Bone Marrow Transplant 15: 595-603.
52. Hu HZ, Li GL, Lim YK, Chan SH, Yap EH (1999) Kinetics of interferongamma secretion and its regulatory factors in the early phase of acute graftversus-host disease. Immunology 98: 379-385.
53. Twigger SN, Pruitt KD, Fernandez-Suarez XM, Karolchik D, Worley KC, et al. (2008) What everybody should know about the rat genome and its online resources. Nat Genet 40: 523-527.
54. Curry JL, Qin JZ, Robinson J, Nickoloff BJ (2003) Reactivity of resident immunocytes in normal and prepsoriatic skin using an ex vivo skin-explant model system. Arch Pathol Lab Med 127: 289-296.
55. Velardi A, Ruggeri L, Mancusi A, Burchielli E, Perruccio K, et al. (2008) Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation. Semin Immunopathol 30: 489-503.
56. Vohra RS, Murphy JE, Walker JH, Ponnambalam S, Homer-Vanniasinkam S (2006) Atherosclerosis and the Lectin-like OXidized low-density lipoprotein scavenger receptor. Trends Cardiovasc Med 16: 60-64.
57. Delneste Y, Magistrelli G, Gauchat J, Haeuw J, Aubry J, et al. (2002) Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17: 353-362.
58. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: (7).
59. Morel J, Simoes C, Da S, Avinens O, Sany J, Combe B, et al. (2003) Polymorphism of HLA-DMA and DMB alleles in patients with systemic lupus erythematosus. J Rheumatol 30: 1485-1490.
60. Spencer KL, Hauser MA, Olson LM, Schmidt S, Scott WK, et al. (2007) Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum Mol Genet 16: 1986-1992.
61. Pawlik A, Kurzawski M, Szczepanik T, Dziedziejko V, Safranow K, et al. (2008) Association of allograft inflammatory factor-1 gene polymorphism with rheumatoid arthritis. Tissue Antigens 72: 171-175.
62. Aly TA, Baschal EE, Jahromi MM, Fernando MS, Babu SR, et al. (2008) Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex. Diabetes 57: 770-776.
63. Chen Q, Reis SE, Kammerer C, Craig WY, LaPierre SE, et al. (2003) Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease. Circulation 107: 3146-3151.
64. Lambert JC, Luedecking-Zimmer E, Merrot S, Hayes A, Thaker U, et al. (2003) Association of 39-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease. J Med Genet 40: 424-430.
65. Dickinson AM, Cavet J, Cullup H, Wang XN, Sviland L, et al. (2001) GvHD risk assessment in hematopoietic stem cell transplantation: role of cytokine gene polymorphisms and an in vitro human skin explant model. Hum Immunol 62: 1266-1276.
66. Baron C, Somogyi R, Greller LD, Rineau V, Wilkinson P, et al. (2007) Prediction of graft-versus-host disease in humans by donor gene-expression profiling. PLoS Med 4: e23.
67. Buzzeo MP, Yang J, Casella G, Reddy V (2008) A preliminary gene expression profile of acute graft-versus-host disease. Cell Transplant 17: 489-494.
68. Takahashi N, Sato N, Takahashi S, Tojo A (2008) Gene-expression profiles of peripheral blood mononuclear cell subpopulations in acute graft-vs-host disease following cord blood transplantation. Exp Hematol 36: 1760-1770.
69. Oh SJ, Cho SB, Park SH, Piao CZ, Kwon SM, et al. (2008) Cell cycle and immune-related processes are significantly altered in chronic GVHD. Bone Marrow Transplant 41: 1047-1057.
70. Ichiba T, Teshima T, Kuick R, Misek DE, Liu C, et al. (2003) Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays. Blood 102: 763-771.
71. Sugerman PB, Faber SB, Willis LM, Petrovic A, Murphy GF, et al. (2004) Kinetics of gene expression in murine cutaneous graft-versus-host disease. Am J Pathol 164: 2189-2202.
72. Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, et al. (1974) Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc 6: 367-371.
73. Dickinson AM, Sviland L, Carey P, Reid MM, Hamilton PJ, et al. (1988) Skin explant culture as a model for cutaneous graft-versus-host disease in humans. Bone Marrow Transplant 3: 323-329.
74. Landgrebe J, Bretz F, Brunner E (2004) Efficient two-sample designs for microarray experiments with biological replications. In Silico Biol 4: 461-470.
75. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, et al. (2002) Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30: e15.
76. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Statist Soc Ser B 57: 289-300.
77. Thomas PD, Kejariwal A, Guo N, Mi H, Campbell MJ, et al. (2006) Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic Acids Res 34: W645-650.
78. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
79. Ademokun JA, Chapman C, Dunn J, Lander D, Mair K, et al. (1997) Umbilical cord blood collection and separation for haematopoietic progenitor cell banking. Bone Marrow Transplant 19: 1023-1028.